Literature DB >> 19252765

MRI criteria in MS patients with negative and positive oligoclonal bands: equal fulfillment of Barkhof's criteria but different lesion patterns.

Hagen B Huttner1, Peter D Schellinger, Tobias Struffert, Gregor Richter, Tobias Engelhorn, Teresa Bassemir, Mathias Mäurer, Meritxell Garcia, Stefan Schwab, Martin Köhrmann, Arnd Doerfler.   

Abstract

In multiple sclerosis (MS) more than 95% of the patients have positive oligoclonal bands (OCB) in the cerebrospinal fluid (CSF). Previous studies have reported differences between patients with and without OCB mainly with regard to clinical parameters such as age, gender, disease duration, and clinical severity. However, several MRI characteristics have also been hypothesized to be distinct, and a varying lesion load in OCB-negative and -positive patients is proposed. In this study, we aimed to evaluate whether Barkhof's diagnostic MRI criteria are unequally frequently fulfilled in OCB-negative and -positive MS patients. We screened our database for all OCB-negative MS patients who had (1) been treated with the diagnosis of a clinical definite relapsing-remitting MS in our institution as well as (2) undergone CSF analysis and MR brain imaging during hospital stay between January 2004 and December 2007. Eleven OCB-negative patients were identified who fulfilled these criteria. In a second step, we carefully matched each of them to two OCB-positive controls according to age, gender, EDSS, and disease duration. The separate analysis of the several parameters of Barkhof's criteria revealed a less frequent prevalence of infratentorial (3/11 vs. 18/22; P = 0.005) and a more frequent occurrence of juxtacortical lesions (10/11 vs. 10/22; P = 0.022) in OCB-negative as compared to OCB-positive patients. The overall fulfillment of the Barkhof criteria did not differ in OCB-negative and -positive patients (7/11 vs. 16/22; P = 0.696). Further analyses of MRI findings between OCB-negative and -positive MS patients might contribute to a better pathophysiological understanding of the genesis and evidence of OCB in the CSF of MS patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19252765     DOI: 10.1007/s00415-009-5081-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  38 in total

Review 1.  Differences between subgroups of MS: MRI findings and correlation with histopathology.

Authors:  Geert Lycklama à Nijeholt; Frederik Barkhof
Journal:  J Neurol Sci       Date:  2003-02-15       Impact factor: 3.181

2.  Relevance of callosal and periventricular MRI lesions to oligoclonal bands in multiple sclerosis.

Authors:  I Nakashima; K Fujihara; H Miyazawa; T Misu; J Fujimori; S Sato; Y Itoyama
Journal:  Acta Neurol Scand       Date:  2006-02       Impact factor: 3.209

3.  Flow rate of cerebrospinal fluid (CSF)--a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases.

Authors:  H Reiber
Journal:  J Neurol Sci       Date:  1994-04       Impact factor: 3.181

4.  Early differential diagnosis of multiple sclerosis using a new oligoclonal band test.

Authors:  Luisa M Villar; Jaime Masjuan; María C Sádaba; Pedro González-Porqué; José Plaza; Alfredo Bootello; José C Alvarez-Cermeño
Journal:  Arch Neurol       Date:  2005-04

5.  Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: a prospective 2-year follow-up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT.

Authors:  K H Lee; S A Hashimoto; J P Hooge; L F Kastrukoff; J J Oger; D K Li; D W Paty
Journal:  Neurology       Date:  1991-05       Impact factor: 9.910

6.  The significance of oligoclonal bands in multiple sclerosis in Japan: relevance of immunogenetic backgrounds.

Authors:  T Fukazawa; S Kikuchi; H Sasaki; K Hamada; T Hamada; K Miyasaka; K Tashiro
Journal:  J Neurol Sci       Date:  1998-06-30       Impact factor: 3.181

Review 7.  Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.

Authors:  M Andersson; J Alvarez-Cermeño; G Bernardi; I Cogato; P Fredman; J Frederiksen; S Fredrikson; P Gallo; L M Grimaldi; M Grønning
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-08       Impact factor: 10.154

8.  Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?

Authors:  M Tintoré; A Rovira; J Río; C Tur; R Pelayo; C Nos; N Téllez; H Perkal; M Comabella; J Sastre-Garriga; X Montalban
Journal:  Neurology       Date:  2007-09-19       Impact factor: 9.910

9.  [Clinical characteristics and neurophysiologic findings in patients with multiple sclerosis without oligoclonal IgG in cerebrospinal fluid].

Authors:  Sarlota Mesaros; Jelena Drulović; Zvonimir Lević
Journal:  Srp Arh Celok Lek       Date:  2003 Mar-Apr       Impact factor: 0.207

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  6 in total

1.  Clinical and cognitive implications of cerebrospinal fluid oligoclonal bands in multiple sclerosis patients.

Authors:  Maria Anagnostouli; Foteini Christidi; Ioannis Zalonis; Chryssoula Nikolaou; Dimitrios Lyrakos; Nikolaos Triantafyllou; Ioannis Evdokimidis; Constantinos Kilidireas
Journal:  Neurol Sci       Date:  2015-07-01       Impact factor: 3.307

Review 2.  Advances in multiple sclerosis research in 2009.

Authors:  Stefan Nessler; Wolfgang Brück
Journal:  J Neurol       Date:  2010-08-06       Impact factor: 4.849

3.  No prognostic value of routine cerebrospinal fluid biomarkers in a population-based cohort of 407 multiple sclerosis patients.

Authors:  Madlyne Becker; Clotilde Latarche; Emilie Roman; Marc Debouverie; Catherine Malaplate-Armand; Francis Guillemin
Journal:  BMC Neurol       Date:  2015-05-13       Impact factor: 2.474

4.  Advanced MRI features in relapsing multiple sclerosis patients with and without CSF oligoclonal IgG bands.

Authors:  Lin Zhao; Jill Abrigo; Qianyun Chen; Cheryl Au; Angel Ng; Ping Fan; Vincent Mok; Wei Qiu; Allan G Kermode; Alexander Y Lau
Journal:  Sci Rep       Date:  2020-08-13       Impact factor: 4.379

5.  Revisiting the Pathoetiology of Multiple Sclerosis: Has the Tail Been Wagging the Mouse?

Authors:  Monokesh K Sen; Mohammed S M Almuslehi; Peter J Shortland; Jens R Coorssen; David A Mahns
Journal:  Front Immunol       Date:  2020-09-29       Impact factor: 7.561

6.  Cerebrospinal fluid evaluation in patients with progressive motor impairment due to critical central nervous system demyelinating lesions.

Authors:  Benan Barakat; Steve Messina; Shreya Nayak; Roman Kassa; Elia Sechi; Eoin P Flanagan; Orhun Kantarci; Brian G Weinshenker; B Mark Keegan
Journal:  Mult Scler J Exp Transl Clin       Date:  2022-01-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.